Cybin acquires license for psychedelic molecules from Mindset

Mugglehead
By Rowan DunneSep 27, 2022, 5:51 pm182 pts
Cybin Inc. (NEO: CYBN) (NYSE AMERICAN: CYBN) has now strengthened its intellectual property reach with an extensive catalogue of psychoactive tryptamine-based molecules. On Tuesday, the company announced that it had acquired an exclusive license to a series of psychedelic compounds from Mindset Pharma…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Why Is Texas Supporting Psychedelics Research While Criminalizing Cannabis? (Op-Ed) 63

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.